Back

dr. A.G. (Alinda) Vos

dr. A.G. (Alinda) Vos

Assistant Professor - medical

Show full profile

Research Output (42)

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE):week 96 results from a randomised, phase 3, non-inferiority trial

Venter Willem D F, Sokhela Simiso, Simmons Bryony, Moorhouse Michelle, Fairlie Lee, Mashabane Nkuli, Serenata Celicia, Akpomiemie Godspower, Masenya Masebole, Qavi Ambar, Chandiwana Nomathemba, McCann Kaitlyn, Norris Shane, Chersich Matthew, Maartens Gary, Lalla-Edward Samanta, Vos Alinda, Clayden Polly, Abrams Elaine, Arulappan Natasha, Hill Andrew Oct 2020, In: The lancet. HIV. 7 , p. e666-e676

Phone Calls to Retain Research Participants and Determinants of Reachability in an African Setting:Observational Study

Draaijer Melvin, Lalla-Edward Samanta Tresha, Venter Willem Daniel Francois, Vos Alinda 30 Sep 2020, In: JMIR formative research. 4 , p. e19138

Cardiovascular Disease Burden in Rural Africa:Does HIV and Antiretroviral Treatment Play a Role?: Baseline Analysis of the Ndlovu Cohort Study

Vos Alinda G, Barth Roos E, Klipstein-Grobusch Kerstin, Tempelman Hugo A, Devillé Walter L J, Dodd Caitlin, Coutinho Roel A, Grobbee Diederick E, 9 Apr 2020, In: Journal of the American Heart Association. 9 10 p.

Heart Rate Variability, HIV and the Risk of Cardiovascular Diseases in Rural South Africa

Godijk Noortje G, Vos Alinda G, Jongen Vita W, Moraba Robert, Tempelman Hugo, Grobbee Diederick E, Coutinho Roel A, Devillé Walter, Klipstein-Grobusch Kerstin 12 Feb 2020, In: Global Heart. 15 , p. 1-9

Obesity and the heart: The impact of obesity beyond the body mass index

Vos A. G. 16 Jan 2020, In: European Journal of Preventive Cardiology. 27 , p. 2004-2005 2 p.

Cardiovascular disease risk and its determinants in people living with HIV across different settings in South Africa

Roozen Gvt, Vos A G, Tempelman H A, Venter Wdf, Grobbee D E, Scheuermaier K, Klipstein-Grobusch K 18 Dec 2019, In: HIV Medicine. 21 , p. 386-396 11 p.

Cardiovascular disease risk in an urban African population:a cross-sectional analysis on the role of HIV and antiretroviral treatment

Vos Alinda G, Hoeve Klariska, Barth Roos E, Peper Joyce, Moorhouse Michelle, Crowther Nigel J, Venter Willem D F, Grobbee Diederick E, Bots Michiel L, Klipstein-Grobusch Kerstin 3 Dec 2019, In: Retrovirology. 16 10 p.

The Utility of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort

Mayne Elizabeth S, Moabi Hellen, Grobbee Diederick E, Barth Roos E, Klipstein-Grobusch Kerstin, Stevens Wendy S, Vos Alinda G, Louw Susan 5 Nov 2019, In: Clinical and Applied Thrombosis/Hemostasis. 25 , p. 1-5 5 p.

Cross-sectional study of the health of southern African truck drivers

Lalla-Edward Samanta Tresha, Fischer Alex Emilio, Venter W D Francois, Scheuermaier Karine, Meel Ruchika, Hankins Catherine, Gomez Gabriela, Klipstein-Grobusch Kerstin, Draaijer Melvin, Vos Alinda G 28 Oct 2019, In: BMJ Open. 9

Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population compared to an HIV-negative control group

Kummerow Maren, Shaddock Erica, Klipstein-Grobusch Kerstin, Barth Roos, Grobbee Diederick, Venter Francois, Feldman Charles, Vos Alinda 26 Sep 2019, In: Southern African Journal of HIV Medicine. 20 7 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not